Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Jul 13, 2017 at 9:40 AM EDT

Short Sellers Hike Bets in Major Biotechs

The June 30 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Jul 13, 2017 at 9:20 AM EDT

Major Pharma Short Sellers Become More Selective

The June 30 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jul 12, 2017 at 10:25 AM EDT

Why Ocular Therapeutix Shares Are Getting Crushed

Ocular Therapeutix shares were absolutely crushed on Wednesday after the company received less than favorable news from the FDA regarding…

Chris Lange | Jul 11, 2017 at 1:20 PM EDT

PetIQ Announces Potential Pricing for IPO

PetIQ intends to price more than 5 million shares in the range of $14 to $16 apiece in an initial…

Chris Lange | Jul 11, 2017 at 12:10 PM EDT

Meet Jefferies Top 12 Picks in the Roaring Biotech Industry

The biotech industry has made a splash in 2017, outperforming practically all the broad markets. With this incredible display, it's…

Chris Lange | Jul 11, 2017 at 10:50 AM EDT

Why Arena Pharmaceuticals Is Knocking It Out of the Park

Shares of Arena Pharmaceuticals saw an incredible gain early Tuesday after the company reported positive results from its mid-stage trial…

Lee Jackson | Jul 11, 2017 at 10:10 AM EDT

3 Red-Hot Medical Tech Stocks That Could Beat Earnings Estimates

Despite the concerns over the struggles of politicians to craft a new health care plan for the United States, the…

Chris Lange | Jul 10, 2017 at 10:25 AM EDT

Kala Pharmaceuticals Gears Up for IPO

Kala Pharmaceuticals intends to price 6 million shares in the range of $14 to $16 apiece in an initial public…

Chris Lange | Jul 7, 2017 at 1:00 PM EDT

FDA Issues an Approval Not Seen in Almost 20 Years

In an incredible move on Friday, the FDA approved Endari for the treatment of patients age five and older with…

Chris Lange | Jul 7, 2017 at 8:50 AM EDT

Why Conatus Pharma Wins With Newest Licensing Agreement

Conatus Pharmaceuticals saw its shares make a handy gain on Friday after the firm announced an exclusive license agreement with…

Chris Lange | Jul 6, 2017 at 8:35 AM EDT

How Transformative Is This Licensing Deal for BeiGene?

This partnership should be fairly transformative for BeiGene, seeing as it can start making some actual money.

Chris Lange | Jul 5, 2017 at 11:45 AM EDT

Athenex Wins Big on Chinese Cancer Drug

Athenex led biotech stocks higher on Wednesday after its Chinese subsidiary submitted an Investigational New Drug application to the China…

Chris Lange | Jul 5, 2017 at 9:50 AM EDT

Array BioPharma’s New FDA Submissions Enough to Excite Investors?

Array BioPharma has announced the submission to the FDA of two New Drug Applications to support the use of the…

Chris Lange | Jul 1, 2017 at 8:25 AM EDT

Top Stocks to Look For on July’s FDA Calendar

24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of July and…

John Harrington | Jun 29, 2017 at 12:20 PM EDT

Report Ties Drop in Childhood Lead Exposure With Crime Decrease

A drop in the exposure to lead among children in their preschool years reduces antisocial behavior and may be a…

1 … 161 162 163 164 165 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Short Sellers Hike Bets in Major Biotechs

Major Pharma Short Sellers Become More Selective

Why Ocular Therapeutix Shares Are Getting Crushed

PetIQ Announces Potential Pricing for IPO

Meet Jefferies Top 12 Picks in the Roaring Biotech Industry

Why Arena Pharmaceuticals Is Knocking It Out of the Park

3 Red-Hot Medical Tech Stocks That Could Beat Earnings Estimates

Kala Pharmaceuticals Gears Up for IPO

FDA Issues an Approval Not Seen in Almost 20 Years

Why Conatus Pharma Wins With Newest Licensing Agreement

How Transformative Is This Licensing Deal for BeiGene?

Athenex Wins Big on Chinese Cancer Drug

Array BioPharma’s New FDA Submissions Enough to Excite Investors?

Top Stocks to Look For on July’s FDA Calendar

Report Ties Drop in Childhood Lead Exposure With Crime Decrease

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Live Nasdaq Composite: Tech Stock Gains Unleashed as Stars Align for Risk-On Trade

PepsiCo vs Coca-Cola: A Decade-Long Fight for Dominance

Micron Rockets 12%, SanDisk Leaps 10% as Tight Memory Supply Fuels Parabolic AI Trade

A $1.25 Million Dividend Portfolio That Pays More Than the Average Teacher Earns in a Year

A $1.25 Million Dividend Portfolio That Pays More Than the Average Teacher Earns in a Year

The IRA and 401(K) Tax Trap That Catches Retirees off Guard

PepsiCo vs Coca-Cola: A Decade-Long Fight for Dominance

Micron Rockets 12%, SanDisk Leaps 10% as Tight Memory Supply Fuels Parabolic AI Trade

Health and Healthcare Articles

All Health and Healthcare Articles

Short Sellers Hike Bets in Major Biotechs

Major Pharma Short Sellers Become More Selective

Why Ocular Therapeutix Shares Are Getting Crushed

PetIQ Announces Potential Pricing for IPO

Meet Jefferies Top 12 Picks in the Roaring Biotech Industry

Why Arena Pharmaceuticals Is Knocking It Out of the Park

3 Red-Hot Medical Tech Stocks That Could Beat Earnings Estimates

Kala Pharmaceuticals Gears Up for IPO

FDA Issues an Approval Not Seen in Almost 20 Years

Why Conatus Pharma Wins With Newest Licensing Agreement

How Transformative Is This Licensing Deal for BeiGene?

Athenex Wins Big on Chinese Cancer Drug

Array BioPharma’s New FDA Submissions Enough to Excite Investors?

Top Stocks to Look For on July’s FDA Calendar

Report Ties Drop in Childhood Lead Exposure With Crime Decrease

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Live Nasdaq Composite: Tech Stock Gains Unleashed as Stars Align for Risk-On Trade

PepsiCo vs Coca-Cola: A Decade-Long Fight for Dominance

Micron Rockets 12%, SanDisk Leaps 10% as Tight Memory Supply Fuels Parabolic AI Trade

A $1.25 Million Dividend Portfolio That Pays More Than the Average Teacher Earns in a Year

Featured Reads

A $1.25 Million Dividend Portfolio That Pays More Than the Average Teacher Earns in a Year

The IRA and 401(K) Tax Trap That Catches Retirees off Guard